Evidence map›Paper›PMID 31852912›Full record

ArticleScientific reports2019

Repeated Porphyromonas gingivalis W83 exposure leads to release pro-inflammatory cytokynes and angiotensin II in coronary artery endothelial cells.

Sergio M Viafara-García, Sandra Johanna Morantes, Yersson Chacon-Quintero, Diana Marcela Castillo, Gloria Inés Lafaurie, Diana Marcela Buitrago

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. MiR-21 modulatesNon-coding RNA research · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. The Roles of Periodontal Bacteria in Atherosclerosis.International journal of molecular sciences · 2023
    Review
  18. Frontiers in immunology · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sergio M Viafara-GarcíaUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogota, Colombia.ORCID http://orcid.org/0000-0002-4208-1422
Sandra Johanna MorantesUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogota, Colombia.ORCID http://orcid.org/0000-0002-7780-2066
Yersson Chacon-QuinteroUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogota, Colombia.ORCID http://orcid.org/0000-0002-2778-6205
Diana Marcela CastilloUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogota, Colombia.ORCID http://orcid.org/0000-0002-1846-7448
Gloria Inés LafaurieUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogota, Colombia.ORCID http://orcid.org/0000-0003-3986-0625
Diana Marcela BuitragoUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogota, Colombia. buitragodianam@unbosque.edu.co.ORCID http://orcid.org/0000-0001-6283-7656
Universidad El Bosque · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of Porphyromonas gingivalis (P. gingivalis) or its virulence factors, including lipopolysaccharide (LPS) not only has been related with periodontitis but also with endothelial dysfunction, a key mechanism involved in the genesis of atherosclerosis and hypertension that involving systemic inflammatory markers as angiotensin II (Ang II) and cytokines. This study compares the effect of repeated and unique exposures of P. gingivalis W83 LPS and live bacteria on the production and expression of inflammatory mediators and vasoconstrictor molecules with Ang II. Human coronary artery endothelial cells (HCAEC) were stimulated with purified LPS of P. gingivalis (1.0, 3.5 or 7.0 μg/mL) or serial dilutions of live bacteria (MOI 1: 100 - 1:0,1) at a single or repeated exposure for a time of 24 h. mRNA expression levels of AGTR1, AGTR2, IL-8, IL-1β and MCP-1 were determined by RT-qPCR, and IL-6, MCP-1, IL-8, IL-1β and GM-CSF levels were measured by flow cytometry, ELISA determined Ang II levels. Live bacteria in a single dose increased mRNA levels of AGTR1, and repeated doses increased mRNA levels of IL-8 and IL-1β (p < 0.05). Repeated exposure of live-P. gingivalis induced significant production IL-6, MCP-1 and GM-CSF (p < 0.05). Moreover, these MCP-1, IL-6 and GM-CSF levels were greater than in cells treated with single exposure (p < 0.05), The expression of AGTR1 and production of Ang II induced by live-P. gingivalis W83 showed a vasomotor effect of whole bacteria in HCAEC more than LPS. In conclusion, the findings of this study suggest that repeated exposure of P. gingivalis in HCAEC induces the activation of proinflammatory and vasoconstrictor molecules that lead to endothelial dysfunction being a key mechanism of the onset and progression of arterial hypertension and atherosclerosis.

Indexed as

Angiotensin IIAtherosclerosisChemokine CCL2Coronary VesselsEndothelial CellsFlow CytometryGene Expression RegulationGranulocyte-Macrophage Colony-Stimulating FactorHumansHypertensionInflammationInterleukin-6LipopolysaccharidesPeriodontitisPorphyromonas gingivalisReceptor, Angiotensin, Type 1AGTR1 protein, humanAngiotensin IICCL2 protein, humanChemokine CCL2Granulocyte-Macrophage Colony-Stimulating FactorInterleukin-6LipopolysaccharidesReceptor, Angiotensin, Type 1RNA, Messenger

Identifiers

PMID31852912
PMCPMC6920421
OpenAlexW2996363989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.